1 citations
,
September 2020 in “Actas Dermo-Sifiliográficas” This article discusses the underutilization of spironolactone in dermatology for conditions like acne, highlighting its potential benefits and good safety profile, but reports no new clinical findings.
26 citations
,
April 2009 in “Australasian Journal of Dermatology” In this study, a 9-year-old girl with female pattern hair loss showed clinical improvement and hair regrowth after six months of daily oral spironolactone.
9 citations
,
August 2001 in “PubMed” This review discusses the classification and diagnosis of hair loss and emphasizes that nonpermanent alopecia can achieve full regrowth with appropriate treatment, but reports no new results.
1 citations
,
April 1992 in “PubMed” This review discusses the clinical features of various types of hair loss, including both common and less common alopecias, and reports no new clinical results.
7 citations
,
September 1987 in “PubMed” This paper reviews the main causes of hair loss seen by dermatologists and reports no new clinical findings, emphasizing the need for comprehensive understanding to manage these conditions effectively.
9 citations
,
April 1986 in “Postgraduate Medicine” This article reviews the causes of hair loss in pediatric and adult populations, emphasizing the importance of distinguishing between primary dermatologic conditions and those related to systemic diseases, but reports no new clinical findings.
101 citations
,
January 1985 in “British Journal of Dermatology” This article discusses oral spironolactone therapy for female patients with acne, hirsutism, or androgenic alopecia and reports no new clinical results.
31 citations
,
January 1981 This abstract reviews the causes and prognosis of alopecia areata but reports no new clinical findings.